Top
TAGLN2 has not been detected as a mutational cancer driver

TAGLN2
Ensembl id ENSG00000158710
Mutated samples
Coding Sequence 67 (1.0%)
Protein Affecting 10 (0.1%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all TAGLN2 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Lung adenocarcinoma No 6 2 0.51
Uterine corpus endometrioid carcinoma No 5 2 0.87
Prostate adenocarcinoma No 1 1 0.41
Breast carcinoma No 2 1 0.09
Lung squamous cell carcinoma No 3 1 0.57
Cutaneous melanoma No 24 1 0.27
Non small cell lung carcinoma No 1 1 3.23
Glioblastoma multiforme No 3 1 0.26
Hepatocarcinoma No 1 0 0.00
Bladder carcinoma No 2 0 0.00
Renal clear cell carcinoma No 4 0 0.00
Chronic lymphocytic leukemia No 1 0 0.00
Serous ovarian adenocarcinoma No 1 0 0.00
Stomach adenocarcinoma No 3 0 0.00
Colorectal adenocarcinoma No 3 0 0.00
Head and neck squamous cell carcinoma No 4 0 0.00
Esophageal carcinoma No 3 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence